miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.

Tian H, Hou L, Xiong YM, Huang JX, She YJ, Bi XB, Song XR.

Open source

DOI
10.3892/or.2014.3657
Published
2014-12-08
Container
Oncol Rep
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/or.2014.3657,
  title = {miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.},
  author = {Tian H and  Hou L and  Xiong YM and  Huang JX and  She YJ and  Bi XB and  Song XR.},
  year = {2015},
  journal = {Oncol Rep},
  doi = {10.3892/or.2014.3657},
  url = {https://doi.org/10.3892/or.2014.3657}
}

RIS

TY  - JOUR
TI  - miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
AU  - Tian H
AU  -  Hou L
AU  -  Xiong YM
AU  -  Huang JX
AU  -  She YJ
AU  -  Bi XB
AU  -  Song XR.
PY  - 2015
JO  - Oncol Rep
DO  - 10.3892/or.2014.3657
UR  - https://doi.org/10.3892/or.2014.3657
ER  - 

APA

H, T., L, H., YM, X., JX, H., YJ, S., XB, B., & XR., S. (2015). miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.. Oncol Rep. https://doi.org/10.3892/or.2014.3657

Source records